220 likes | 481 Views
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome. Bayu Lestari. What will be Impaired in This Patient?. Insulin Resistance?. Dyslipidemia? (High TG, High LDL, Low LDL). T2DM?. Metabolic Syndrome. Obese. Background.
E N D
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari
What will be Impaired in This Patient? Insulin Resistance? Dyslipidemia? (High TG, High LDL, Low LDL) T2DM? Metabolic Syndrome Obese
Background High prevalence of metabolic syndrome: relation between glucose and lipid metabolism Various clinical manifestations: T2DM, obese, dyslipidemia New therapeutic approach required for efficient and high efficacy AMPK was reported as potent molecular target for metabolic syndrome therapy
Aim Discuss about Metabolic Syndrome Discuss about AMPK as molecular target for therapy
Metabolic Syndrome Cluster of syndrome: insulin resistance, high blood glucose, dyslipidemia, obese Impairment both glucose metabolism and lipid metabolism Correlation between glucose and lipid metabolism?
Role AMPK on GLUT4 Enhanced translocation of GLUT4 Enhanced expression of GLUT4 gene (Zheng et al, 2009) Insulin independent pathway?
Role AMPK in Insulin Sensitivity Insulin-mTOR pathway activation & phosphorylation S6 kinase I, down-regulation insulin receptor substrate-1 (IRS1) decrease insulin signalling(Zheng et al, 2009)
Role AMPK in Mitochondrial Biogenesis AMPK activation improve mitochondrial function via expression of peroxisome proliferator-activated receptor-γ (PPAR-γ) coactivator-1α (PGC-1α) reduce insulin resistance reduce development of T2DM (Zheng et al, 2009)
Role AMPK in Lipid Metabolism Lipogenesis Lipid Oxidation
Conclusion Metabolic syndrome: cluster of syndromes (insulin resistance, dyslipidemia, obese) AMPK has beneficial role as molecular target for metabolic syndrome’s therapy